Skip to main content
Video

Gil Melmed, MD, on Comparative Effectiveness in Ulcerative Colitis

Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using data from comparative effectiveness studies to help guide decisions when choosing therapies for patients with ulcerative colitis.

 

Gil Y Melmed, MD, is director of Inflammatory Bowel Disease Clinical Research and codirector of the Clinical Inflammatory Bowel Disease program at Cedars-Sinai Medical Center in Los Angeles, California.

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the AIBD Network or HMP Global, its employees, and affiliates.